SymBiosis

Investments by market, targeted sectors and preferred funding rounds

Name - SymBiosis
Web -
Description -
Investor Type -
Preferred rounds -
Location

Investments by industry

biotech - 33%
healthtech - 67%

Number of investments: 3

SymBiosis invested in eGenesis during a round worth $125,000,000 - 3/2/2021
SymBiosis invested in Micronoma during a round worth $3,500,000 - 2/22/2021
SymBiosis invested in MaaT Pharma during a round worth 7,350,000 - 12/2/2020